Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Črt, Dragar"'
Publikováno v:
Nanomaterials, Vol 14, Iss 11, p 949 (2024)
Hydrophilic nanofibers offer promising potential for the delivery of drugs with diverse characteristics. Yet, the effects of different drugs incorporated into these nanofibers on their properties remain poorly understood. In this study, we systematic
Externí odkaz:
https://doaj.org/article/2974f509050341bc8cf448f205184b69
Publikováno v:
Pharmaceutics, Vol 15, Iss 6, p 1619 (2023)
To improve the physical stability of nanoparticle dispersions, several methods for their transformation into stable and easily dispersible dry products have been investigated thus far. Recently, electrospinning was shown to be a novel nanoparticle di
Externí odkaz:
https://doaj.org/article/7e891964f1c24e158379015fc15c1827
Publikováno v:
Pharmaceutics; Volume 15; Issue 6; Pages: 1619
To improve the physical stability of nanoparticle dispersions, several methods for their transformation into stable and easily dispersible dry products have been investigated thus far. Recently, electrospinning was shown to be a novel nanoparticle di
Autor:
Črt Dragar, Tanja Potrč, Sebastjan Nemec, Robert Roškar, Nives Belcar, Slavko Kralj, Mirjana Gašperlin, Petra Kocbek
Publikováno v:
IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science.
Publikováno v:
International journal of pharmaceutics, vol. 629, 122389, 2022.
One of the key technological challenges in the development of iron-oxide-based magnetic nanoparticles (MNPs) is their long-term physical stability in colloidal dispersions. This can be improved by their transformation into a dry form. Here, we introd
Autor:
Slavko Kralj, Robert Roškar, Tanja Potrč, Črt Dragar, Stane Pajk, Petra Kocbek, Mirjana Gašperlin, Sebastjan Nemec
Publikováno v:
III. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science.
Publikováno v:
International Journal of Pharmaceutics. 597:120348
Despite the intensive development and unique properties of iron-oxide-based magnetic nanoparticles (MNPs), their use as drug delivery systems has not yet entered clinical practice. There also remains a lack of data on their toxicity profile and behav